Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Post-traumatic Stress Disorder Symptom Substitution as a Cause of Functional Neurological Disorder.

Burke MJ, Lizano P, Jacobs C, Stern TA.

Psychosomatics. 2019 Mar 22. pii: S0033-3182(19)30058-1. doi: 10.1016/j.psym.2019.03.003. [Epub ahead of print] No abstract available.

PMID:
31005267
2.

What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy?

Taraseviciute A, Broglie L, Phelan R, Bhatt NS, Becktell K, Burke MJ.

J Pediatr Hematol Oncol. 2019 Apr 9. doi: 10.1097/MPH.0000000000001479. [Epub ahead of print]

PMID:
30973486
3.

Receptor tyrosine kinase inhibitors cause dysfunction in adult rat cardiac fibroblasts in vitro.

Burke MJ, Walmsley R, Munsey TS, Smith AJ.

Toxicol In Vitro. 2019 Mar 22;58:178-186. doi: 10.1016/j.tiv.2019.03.026. [Epub ahead of print]

PMID:
30910525
4.

Checkpoint inhibition of PD-L1 and CTLA-4 in a child with refractory acute leukemia.

Broglie L, Gershan J, Burke MJ.

Int J Hematol Oncol. 2019 Jan 16;8(1):IJH10. doi: 10.2217/ijh-2018-0009. eCollection 2019 Feb.

5.

Allogeneic Hematopoietic Cell Transplantation Provides No Benefit for Patients With Hypodiploid Acute Lymphoblastic Leukemia.

Burke MJ.

J Clin Oncol. 2019 Apr 1;37(10):763-764. doi: 10.1200/JCO.19.00143. Epub 2019 Feb 22. No abstract available.

PMID:
30794478
6.

Sham tDCS: A hidden source of variability? Reflections for further blinded, controlled trials.

Fonteneau C, Mondino M, Arns M, Baeken C, Bikson M, Brunoni AR, Burke MJ, Neuvonen T, Padberg F, Pascual-Leone A, Poulet E, Ruffini G, Santarnecchi E, Sauvaget A, Schellhorn K, Suaud-Chagny MF, Palm U, Brunelin J.

Brain Stimul. 2019 May - Jun;12(3):668-673. doi: 10.1016/j.brs.2018.12.977. Epub 2019 Jan 2.

PMID:
30639235
7.

Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG.

Burke MJ, Salzer WL, Devidas M, Dai Y, Gore L, Hilden JM, Larsen E, Rabin KR, Zweidler-McKay PA, Borowitz MJ, Wood B, Heerema NA, Carroll AJ, Winick N, Carroll WL, Raetz EA, Loh ML, Hunger SP.

Haematologica. 2019 May;104(5):986-992. doi: 10.3324/haematol.2018.204545. Epub 2018 Dec 13.

8.

Optical stimulation of cardiac cells with a polymer-supported silicon nanowire matrix.

Parameswaran R, Koehler K, Rotenberg MY, Burke MJ, Kim J, Jeong KY, Hissa B, Paul MD, Moreno K, Sarma N, Hayes T, Sudzilovsky E, Park HG, Tian B.

Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):413-421. doi: 10.1073/pnas.1816428115. Epub 2018 Dec 11.

PMID:
30538202
9.

Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation.

Burke MJ, Kaptchuk TJ, Pascual-Leone A.

Ann Neurol. 2019 Jan;85(1):12-20. doi: 10.1002/ana.25387. Epub 2019 Jan 8. No abstract available.

PMID:
30521083
10.

Neurostimulation for Functional Neurological Disorder: Evaluating Longitudinal Neurophysiology.

Burke MJ, Isayama R, Jegatheeswaran G, Gunraj C, Feinstein A, Lang AE, Chen R.

Mov Disord Clin Pract. 2018 Oct 1;5(5):561-563. doi: 10.1002/mdc3.12651. eCollection 2018 Sep-Oct. No abstract available.

PMID:
30515447
11.

Visualizing Kinetically Robust CoIII4L6 Assemblies in Vivo: SPECT Imaging of the Encapsulated [99mTc]TcO4- Anion.

Burke BP, Grantham W, Burke MJ, Nichol GS, Roberts D, Renard I, Hargreaves R, Cawthorne C, Archibald SJ, Lusby PJ.

J Am Chem Soc. 2018 Dec 12;140(49):16877-16881. doi: 10.1021/jacs.8b09582. Epub 2018 Dec 3.

PMID:
30485075
12.

Association of Concussion With the Risk of Suicide: A Systematic Review and Meta-Analysis.

Fralick M, Sy E, Hassan A, Burke MJ, Mostofsky E, Karsies T.

JAMA Neurol. 2018 Nov 12. doi: 10.1001/jamaneurol.2018.3487. [Epub ahead of print]

PMID:
30419085
13.

Lesion network localization of free will.

Darby RR, Joutsa J, Burke MJ, Fox MD.

Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10792-10797. doi: 10.1073/pnas.1814117115. Epub 2018 Oct 1.

14.

Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia.

Andolina JR, Burke MJ, Hijiya N, Chaudhury S, Schultz KR, Roth ME.

Biol Blood Marrow Transplant. 2019 Feb;25(2):321-327. doi: 10.1016/j.bbmt.2018.09.029. Epub 2018 Sep 26.

PMID:
30267760
15.

Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.

Ziegler AL, Freeman CK, Fogle CA, Burke MJ, Davis JL, Cook VL, Southwood LL, Blikslager AT.

Equine Vet J. 2019 May;51(3):329-335. doi: 10.1111/evj.13013. Epub 2018 Sep 21.

PMID:
30156312
16.

Central tendency and matched difference approaches for assessing interrater agreement.

Burke MJ, Cohen A, Doveh E, Smith-Crowe K.

J Appl Psychol. 2018 Nov;103(11):1198-1229. doi: 10.1037/apl0000325. Epub 2018 Jul 2.

PMID:
29963898
17.

Epigenetic Therapy in a Patient With Down Syndrome and Refractory Acute Myeloid Leukemia.

Becktell K, Houser K, Burke MJ.

J Pediatr Hematol Oncol. 2019 Jan;41(1):e38-e40. doi: 10.1097/MPH.0000000000001158.

PMID:
29668549
18.

Evaluation of digital cryotherapy using a commercially available sleeve style ice boot in healthy horses and horses receiving i.v. endotoxin.

Burke MJ, Tomlinson JE, Blikslager AT, Johnson AL, Dallap-Schaer BL.

Equine Vet J. 2018 Nov;50(6):848-853. doi: 10.1111/evj.12842. Epub 2018 May 7.

PMID:
29654616
19.

Immediate Preoperative and Postoperative Management for Strabismus Surgery.

Burke MJ, Chan RVP, Friedman IB, Suh DW, Wagner RS.

J Pediatr Ophthalmol Strabismus. 2018 Mar 1;55(2):77-79. doi: 10.3928/01913913-20171016-01. No abstract available.

PMID:
29543973
20.

Resilience linked to personality dimensions, alexithymia and affective symptoms in motor functional neurological disorders.

Jalilianhasanpour R, Williams B, Gilman I, Burke MJ, Glass S, Fricchione GL, Keshavan MS, LaFrance WC Jr, Perez DL.

J Psychosom Res. 2018 Apr;107:55-61. doi: 10.1016/j.jpsychores.2018.02.005. Epub 2018 Feb 13.

21.

Photoelectrochemical modulation of neuronal activity with free-standing coaxial silicon nanowires.

Parameswaran R, Carvalho-de-Souza JL, Jiang Y, Burke MJ, Zimmerman JF, Koehler K, Phillips AW, Yi J, Adams EJ, Bezanilla F, Tian B.

Nat Nanotechnol. 2018 Mar;13(3):260-266. doi: 10.1038/s41565-017-0041-7. Epub 2018 Feb 19.

22.

Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature.

Schulte RR, Madiwale MV, Flower A, Hochberg J, Burke MJ, McNeer JL, DuVall A, Bleyer A.

Leuk Lymphoma. 2018 Oct;59(10):2360-2368. doi: 10.1080/10428194.2018.1435873. Epub 2018 Feb 12.

PMID:
29431566
23.

Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.

Salzer WL, Burke MJ, Devidas M, Chen S, Gore L, Larsen EC, Borowitz M, Wood B, Heerema NA, Carroll AJ, Hilden JM, Loh ML, Raetz EA, Winick NJ, Carroll WL, Hunger SP.

Cancer. 2018 Mar 15;124(6):1150-1159. doi: 10.1002/cncr.31099. Epub 2017 Dec 19.

24.

Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group.

Bhojwani D, Burke MJ, Horton T, Ziegler DS, Sulis ML, Schultz KR, Wayne A, Izraeli S, Chang BH.

Pediatr Hematol Oncol. 2017 Sep - Oct;34(6-7):355-364. doi: 10.1080/08880018.2017.1395937. Epub 2017 Nov 30.

25.

Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials.

Burke MJ, Devidas M, Maloney K, Angiolillo A, Schore R, Dunsmore K, Larsen E, Mattano LA Jr, Salzer W, Winter SS, Carroll W, Winick NJ, Loh ML, Raetz E, Hunger SP, Bleyer A.

Leuk Lymphoma. 2018 Jul;59(7):1624-1633. doi: 10.1080/10428194.2017.1397658. Epub 2017 Nov 8.

26.

Evaluation of the analgesic and pharmacokinetic properties of transdermally administered fentanyl in goats.

Burke MJ, Soma LR, Boston RC, Rudy JA, Schaer TP.

J Vet Emerg Crit Care (San Antonio). 2017 Sep;27(5):539-547. doi: 10.1111/vec.12644.

PMID:
28877414
27.

High-Resolution Patterned Cellular Constructs by Droplet-Based 3D Printing.

Graham AD, Olof SN, Burke MJ, Armstrong JPK, Mikhailova EA, Nicholson JG, Box SJ, Szele FG, Perriman AW, Bayley H.

Sci Rep. 2017 Aug 1;7(1):7004. doi: 10.1038/s41598-017-06358-x.

28.

Cohesin Mutations in Myeloid Malignancies.

Fisher JB, McNulty M, Burke MJ, Crispino JD, Rao S.

Trends Cancer. 2017 Apr;3(4):282-293. doi: 10.1016/j.trecan.2017.02.006. Review.

29.

Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes.

Schloemer NJ, Brickler M, Hoffmann R, Pan A, Simpson P, McFadden V, Block J, Tower RL 2nd, Burke MJ.

J Pediatr Hematol Oncol. 2017 Jul;39(5):e254-e258. doi: 10.1097/MPH.0000000000000838.

30.

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

Reshmi SC, Harvey RC, Roberts KG, Stonerock E, Smith A, Jenkins H, Chen IM, Valentine M, Liu Y, Li Y, Shao Y, Easton J, Payne-Turner D, Gu Z, Tran TH, Nguyen JV, Devidas M, Dai Y, Heerema NA, Carroll AJ 3rd, Raetz EA, Borowitz MJ, Wood BL, Angiolillo AL, Burke MJ, Salzer WL, Zweidler-McKay PA, Rabin KR, Carroll WL, Zhang J, Loh ML, Mullighan CG, Willman CL, Gastier-Foster JM, Hunger SP.

Blood. 2017 Jun 22;129(25):3352-3361. doi: 10.1182/blood-2016-12-758979. Epub 2017 Apr 13.

31.

100 years of occupational safety research: From basic protections and work analysis to a multilevel view of workplace safety and risk.

Hofmann DA, Burke MJ, Zohar D.

J Appl Psychol. 2017 Mar;102(3):375-388. doi: 10.1037/apl0000114. Epub 2017 Jan 26. Review.

PMID:
28125258
32.

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.

Gu Z, Churchman M, Roberts K, Li Y, Liu Y, Harvey RC, McCastlain K, Reshmi SC, Payne-Turner D, Iacobucci I, Shao Y, Chen IM, Valentine M, Pei D, Mungall KL, Mungall AJ, Ma Y, Moore R, Marra M, Stonerock E, Gastier-Foster JM, Devidas M, Dai Y, Wood B, Borowitz M, Larsen EE, Maloney K, Mattano LA Jr, Angiolillo A, Salzer WL, Burke MJ, Gianni F, Spinelli O, Radich JP, Minden MD, Moorman AV, Patel B, Fielding AK, Rowe JM, Luger SM, Bhatia R, Aldoss I, Forman SJ, Kohlschmidt J, Mrózek K, Marcucci G, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Paietta E, Willman CL, Loh ML, Hunger SP, Mullighan CG.

Nat Commun. 2016 Nov 8;7:13331. doi: 10.1038/ncomms13331.

33.

Identification of High-risk Cryptic CRLF2 Rearrangements in B-Cell Acute Lymphoblastic Leukemia Utilizing an FGFR3/IGH Dual-Color Dual-Fusion DNA Probe Set.

Robin AJ, Peterson JF, Grignon JW Jr, Gheorghe G, Burke MJ, vanTuinen P.

J Pediatr Hematol Oncol. 2017 May;39(4):e207-e210. doi: 10.1097/MPH.0000000000000691.

PMID:
27820126
34.

Unique CT Perfusion Imaging in a Case of HaNDL: New Insight into HaNDL Pathophysiology and Vasomotor Principles of Cortical Spreading Depression.

Burke MJ, Lamb MJ, Hohol M, Lay C.

Headache. 2017 Jan;57(1):129-134. doi: 10.1111/head.12968. Epub 2016 Oct 24.

PMID:
27774587
35.

Oncolytic Seneca Valley Virus: past perspectives and future directions.

Burke MJ.

Oncolytic Virother. 2016 Sep 6;5:81-9. doi: 10.2147/OV.S96915. eCollection 2016. Review.

36.

Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia.

Burke MJ, Rheingold SR.

Leuk Lymphoma. 2017 Mar;58(3):540-551. doi: 10.1080/10428194.2016.1213826. Epub 2016 Aug 22. Review.

PMID:
27546298
37.

Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.

Sun W, Orgel E, Malvar J, Sposto R, Wilkes JJ, Gardner R, Tolbert VP, Smith A, Hur M, Hoffman J, Rheingold SR, Burke MJ, Wayne AS.

Pediatr Blood Cancer. 2016 Nov;63(11):1943-8. doi: 10.1002/pbc.26129. Epub 2016 Jul 20.

PMID:
27437864
38.

Orthogonal Selection and Fixing of Coordination Self-Assembly Pathways for Robust Metallo-organic Ensemble Construction.

Burke MJ, Nichol GS, Lusby PJ.

J Am Chem Soc. 2016 Jul 27;138(29):9308-15. doi: 10.1021/jacs.6b05364. Epub 2016 Jul 13.

PMID:
27351912
39.

A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.

Rodriguez V, Kairalla J, Salzer WL, Raetz EA, Loh ML, Carroll AJ, Heerema NA, Wood BL, Borowitz MJ, Burke MJ, Asselin BL, Devidas M, Winick NJ, Carroll WL, Hunger SP, Dreyer ZE.

J Pediatr Hematol Oncol. 2016 Aug;38(6):409-17. doi: 10.1097/MPH.0000000000000589.

40.

Minimal Residual Disease in NPM1-Mutated AML.

Burke MJ.

N Engl J Med. 2016 Feb 4;374(5):481-2. doi: 10.1056/NEJMe1515525. Epub 2016 Jan 20. No abstract available.

PMID:
26789634
41.

Prosthetic Mesh for Obliteration of the Nephrosplenic Space in Horses: 26 Clinical Cases.

Burke MJ, Parente EJ.

Vet Surg. 2016 Feb;45(2):201-7. doi: 10.1111/vsu.12434. Epub 2016 Jan 15.

PMID:
26767324
42.

Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples.

Lu BY, Thanawala SU, Zochowski KC, Burke MJ, Carroll WL, Bhatla T.

Leuk Lymphoma. 2016 Aug;57(8):1938-41. doi: 10.3109/10428194.2015.1110747. Epub 2016 Jan 4. No abstract available.

PMID:
26726842
43.

Emerging immunotherapy in pediatric lymphoma.

Erker C, Harker-Murray P, Burke MJ.

Future Oncol. 2016 Jan;12(2):257-70. doi: 10.2217/fon.15.282. Epub 2015 Nov 30. Review.

PMID:
26616565
44.

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Eldjerou L, Frangoul H, Guilcher GMT, Hayashi RJ, Ibrahim A, Kasow KA, Leung WH, Olsson RF, Pulsipher MA, Shah N, Shah NN, Thiel E, Talano JA, Kitko CL.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2154-2159. doi: 10.1016/j.bbmt.2015.08.023. Epub 2015 Aug 29.

45.

Are Adult Ureteroscopes Safe in the Management of Urolithiasis in a Pediatric Population?

Nason GJ, Headon R, Burke MJ, Aslam A, Kelly ME, Giri SK, Flood HD.

Curr Urol. 2015 May;8(1):26-8. doi: 10.1159/000365684. Epub 2015 May 20.

46.

NICE guidance on pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib.

Burke MJ, George E, Adler AI.

Lancet Oncol. 2015 May;16(5):492-3. doi: 10.1016/S1470-2045(15)70135-X. Epub 2015 Mar 25. No abstract available.

PMID:
25818587
47.

On-table urethral catheterisation during laparoscopic appendicectomy: Is it necessary?

Nason GJ, Baig SN, Burke MJ, Aslam A, Kelly ME, Walsh LG, Flood HD, Giri SK.

Can Urol Assoc J. 2015 Jan-Feb;9(1-2):55-8. doi: 10.5489/cuaj.2341.

48.

Non-equilibrium cobalt(iii) "click" capsules.

Symmers PR, Burke MJ, August DP, Thomson PIT, Nichol GS, Warren MR, Campbell CJ, Lusby PJ.

Chem Sci. 2015 Jan 1;6(1):756-760. doi: 10.1039/c4sc03036b. Epub 2014 Oct 7.

49.

In search of evidence-based treatment for concussion: characteristics of current clinical trials.

Burke MJ, Fralick M, Nejatbakhsh N, Tartaglia MC, Tator CH.

Brain Inj. 2015;29(3):300-5. doi: 10.3109/02699052.2014.974673. Epub 2014 Nov 10. Review.

50.

Functional neuroimaging of conversion disorder: the role of ancillary activation.

Burke MJ, Ghaffar O, Staines WR, Downar J, Feinstein A.

Neuroimage Clin. 2014 Sep 30;6:333-9. doi: 10.1016/j.nicl.2014.09.016. eCollection 2014.

Supplemental Content

Loading ...
Support Center